Navigation Links
World Neurostimulation Market to Reach $5.2 Billion by 2012, According to New Report by Global Industry Analysts
Date:11/3/2008

Driven by technology advancements, rising consumer awareness, and development of sophisticated implantable neurostimulation devices, world market for neurostimulation is projected to reach $5.2 billion by the year 2012. Conducive demographics like the aging world population offers ample opportunities for growth in the upcoming years. Emergence of new indications for the use of the neurostimulation therapy is expected to result in expanded market opportunities.

San Jose, CA (PRWEB) November 3, 2008 -- The world neurostimulation market stands enthused by the growing base of aging population, and the resultant rise in age-related diseases such as, Parkinson's, and Alzheimer's disease. Widespread prevalence of neurological disorders and conditions, and the associated costs to society in terms of declining productivity, and reduced quality of life, offer a business case for the neurostimulation treatment modality. Demand for a higher quality of life, rising awareness among both physicians and patients, and improved patient outcomes are together, helping drive growth in the market. Influx of new players is giving rise to increased investments and research and developments. This is expected to lead to a spurt in technology innovations, and development of novel, advanced products, such as closed-loop system neurostimulators, which are designed to continuously stimulate the nervous system. As stated by the recent report published by Global Industry Analysts, Inc., the United States ranks as the single largest market for neurostimulation worldwide, more than 75% share estimated in the year 2008. Innovations in the field of brain imaging, interactive computer guidance devices, and single cell microelectrode recordings, are all helping drive the effectiveness, and hence growth of neurostimulation. With public and private health insurance companies mulling reimbursements for neurostimulation procedures and devices, the market stands to gain attractively in the medium to long run.        

Guided by strong research and development agendas, growth in US market is projected at a CAGR of about 17% for the period 2007 through 2012. In the world spinal cord stimulators market, strong growth is expected to stem from implantable pulse generator (IPG) segment, which is expected to reach US $2.17 billion by 2012. World market for vagus nerve stimulators is projected to grow at a projected CAGR of 22.17% over the period 2007 to 2012. In the United States, revenues in the deep brain stimulators market are projected to rise by US$607.8 million over the period 2007 to 2012.

Leading global and regional players operating in the industry include Boston Scientific Corp, St. Jude Medical Inc, Cyberonics Inc, Medtronic Inc, Afferent Corp, Cyberkinetics Neurotechnology Systems Inc, Northstar Neuroscience Inc, and Synapse Biomedical Inc, among others.

The report titled "Neurostimulation: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of the market trends, drivers, issues, and challenges. Richly annotated with authoritative, and unbiased commentaries, and hard-to-find statistical facts, the report provides unequivocal views on future potential while throwing light on the prevailing climate in key product markets. Product markets analyzed in the report include Spinal Cord Stimulators (SCS) (Radio Frequency (RF) System, and Implantable Pulse Generator (IPG)), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES). Latent demand patterns in product markets are quantified across the United States, and Rest of World. Also provided in the report is an enumeration of recent mergers, acquisitions, and other strategic industry activities.

For more details about this research report, please visit http://www.strategyr.com/Neurostimulation_Market_Report.asp.

About Global Industry Analysts, Inc.:
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/neurostimulation/spinal_cord_stimulators/prweb1553484.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. HTH Worldwide Ranked Number 21 in Deloittes Fast 50 Program for Greater Philadelphia
2. HealthWorldNet.com Receives Three Excellence Awards
3. Esteemed Emergency Medicine Physician Appointed to TeleHealth World Magazine Editorial Advisory Board
4. World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
5. Repair and healing of osteoporotic fractures a focus of upcoming IOF World Congress on Osteoporosis
6. Considering Revision Surgery? Board Certified Plastic Surgeon and Washington DC-based Dr. Mark E. Richards Pioneers Facelift Revisions Attracting Patients Worldwide
7. WorldHeart Announces Effectiveness of Reverse Stock Split
8. Our cheatin brain: The brains clever way of showing us the world as a whole
9. Several US Children Among Worldwide Heroes for Inspirational Fundraising Efforts with Celine Dion
10. World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc.
11. University Of Minnesota Gives 11,538 Flu Shots Tuesday, Shattering Guinness World Record for Most Flu Shots in a Single Day
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Neurostimulation Market to Reach $5.2 Billion by 2012, According to New Report by Global Industry Analysts
(Date:3/30/2017)... ... March 30, 2017 , ... AudioEducator, a leader ... Preventing Hospital Readmissions Through Discharge Planning ” with noted expert Sue Dill Calloway, ... conference discusses strategies to prevent readmissions in light of the most recent programs ...
(Date:3/29/2017)... York City, NY (PRWEB) , ... March 29, ... ... body for men’s and women’s professional squash, announced it has enlisted New York ... partner. The agency will develop and procure sponsorship opportunities for the Professional ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... IN (PRWEB) , ... March 29, 2017 , ... ... Study, this webinar provides insight into the challenges employers face in trying to ... complexity of managing employee benefits programs? Adding to the growing complexity, companies ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Novartis announced today that the ... the company,s Biologics License Application (BLA) filing and ... chimeric antigen receptor T cell (CAR-T) therapy, in ... patients with B-cell acute lymphoblastic leukemia (ALL). This ... a CAR-T. The priority review designation is expected ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Treated at Proton Therapy Centers & Forecast" report to their offering. ... The South Korean Proton ... market size in 2016. The Untapped Proton Therapy Market for ... in 2016. Proton Therapy plays an important role in ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology: